Page last updated: 2024-10-21

1,3-dipropyl-8-cyclopentylxanthine and Cancer of Skin

1,3-dipropyl-8-cyclopentylxanthine has been researched along with Cancer of Skin in 1 studies

DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Merighi, S1
Varani, K1
Gessi, S1
Cattabriga, E1
Iannotta, V1
Ulouglu, C1
Leung, E1
Borea, PA1

Other Studies

1 other study available for 1,3-dipropyl-8-cyclopentylxanthine and Cancer of Skin

ArticleYear
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line.
    British journal of pharmacology, 2001, Volume: 134, Issue:6

    Topics: Adenosine Deaminase; Binding, Competitive; Calcium; Cell Membrane; Cyclic AMP; Humans; Melanoma, Exp

2001